About Centaur Pharmaceuticals
Centaur Pharmaceuticals is a company based in Mumbai (India) founded in 1978. It operates as a Professional Services and Reseller / Distribution. Centaur Pharmaceuticals has raised $7 million across 1 funding round from investors including SIDBI Venture Capital. The company has 3,274 employees as of October 11, 2024. Centaur Pharmaceuticals offers products and services including API Solutions, Formulations, and Clinical Research. Centaur Pharmaceuticals operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
- Employees 3274 as on 11 Oct, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Centaur Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 15 Oct, 1980
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$105.61 M (USD)-6.18as on Mar 31, 2023
-
Net Profit
$12.89 M (USD)-42.94as on Mar 31, 2023
-
EBITDA
$19.44 M (USD)-40.72as on Mar 31, 2023
-
Total Equity Funding
$7 M (USD)
in 1 rounds
-
Latest Funding Round
$7 M (USD), Series A
May 23, 2008
- Investors
-
Employee Count
3274
as on Oct 11, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Centaur Pharmaceuticals
Centaur Pharmaceuticals offers a comprehensive portfolio of products and services, including API Solutions, Formulations, and Clinical Research.
Active pharmaceutical ingredients are developed for drug manufacturing.
Finished dosage forms are produced for various treatments.
Clinical research services are provided for drug development.
People of Centaur Pharmaceuticals
Unlock access to complete
Funding Insights of Centaur Pharmaceuticals
Centaur Pharmaceuticals has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7 million completed in May 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Centaur Pharmaceuticals
Centaur Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SIDBI Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital management for SMEs and startups in India.
|
Locked | Locked | Locked |
Investor details for Centaur Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Centaur Pharmaceuticals
Investment portfolio details for Centaur Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Centaur Pharmaceuticals
Detailed financials for Centaur Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Centaur Pharmaceuticals Comparisons
Peer comparison for Centaur Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Centaur Pharmaceuticals
Centaur Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Centaur Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Centaur Pharmaceuticals
Complete news archive for Centaur Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centaur Pharmaceuticals
Centaur Pharmaceuticals was founded in 1978 and raised its 1st funding round 30 years after it was founded.
Centaur Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Centaur Pharmaceuticals is a funded company, having raised a total of $7M across 1 funding round to date.
As of Oct 11, 2024, the latest employee count at Centaur Pharmaceuticals is 3,274.
Annual revenue of Centaur Pharmaceuticals is $105.61M as on Mar 31, 2023.
Centaur Pharmaceuticals is involved in the development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms (FDF). The company operates across various therapeutic areas including ENT, pediatrics, ophthalmology, neurology, nephrology, diabetology, and cardiology. Comprehensive solutions are provided through synergies in RD, clinical research, and contract research and manufacturing services (CRAM). Facilities are maintained in multiple locations across India to support its integrated pharmaceutical value chain. End-to-end solutions are offered to prestigious partners in the global pharmaceutical industry.
Centaur Pharmaceuticals's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Centaur Pharmaceuticals offers API Solutions, Formulations, and Clinical Research.
Centaur Pharmaceuticals has 1 investor. Key investors include SIDBI Venture Capital.
The valuation of Centaur Pharmaceuticals is $22.55M as of May 2008.